Anticancer 02
Santa Cruz Biotechnology now offers a broad range of anticancer compounds for use in various applications. Anticancer compounds, which target and inhibit the growth of cancer cells, are critical in scientific research for understanding the molecular and cellular mechanisms of cancer development and progression. These compounds are extensively used in studies focusing on cell cycle regulation, apoptosis, and signaling pathways that are altered in cancerous cells. Researchers utilize anticancer compounds to investigate the genetic and epigenetic changes driving cancer, providing insights into tumor biology and the identification of essential targets. In environmental science, these compounds help study the impact of environmental factors on cancer incidence and progression. They also play a role in agriculture, where research focuses on the potential carcinogenic effects of various pesticides and herbicides, aiming to develop safer agricultural practices. Additionally, anticancer compounds are pivotal in biochemistry and molecular biology for developing assays to screen for potential carcinogens and understanding the mechanisms of chemical-induced carcinogenesis. The broad applicability and critical importance of anticancer compounds in multiple scientific disciplines underscore their role in advancing research, improving environmental health, and supporting agricultural safety. View detailed information on our available anticancer compounds by clicking on the product name.
Items 31 to 40 of 499 total
Display:
10 items per page
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Medroxyprogesterone 17-Acetate | 71-58-9 | sc-205744 sc-205744A | 500 mg 1 g | $67.00 $99.00 | ||
Medroxyprogesterone 17-Acetate is a synthetic progesterone receptor agonist | ||||||
Octylonium Bromide | 26095-59-0 | sc-201035 sc-201035A | 5 mg 25 mg | $154.00 $583.00 | 3 | |
Octylonium Bromide is a PAF-R inhibitor | ||||||
p53 Activator III, RITA | 213261-59-7 | sc-202753 sc-202753A sc-202753B sc-202753C | 1 mg 10 mg 100 mg 500 mg | $112.00 $273.00 $1564.00 $5205.00 | 9 | |
p53 Activator III, RITA is a trycyclic thiophene derivative that binds MDM2, activates p53 and induces apoptosis | ||||||
SU 6668 | 252916-29-3 | sc-204309 sc-204309A | 10 mg 50 mg | $127.00 $712.00 | 2 | |
SU 6668 is an antiproliferating agent and ATP-competitive PDGFR, Flk-1/KDR (VEGF), and FGFR inhibitor | ||||||
WYE-354 | 1062169-56-5 | sc-364652 sc-364652A | 10 mg 50 mg | $286.00 $1200.00 | ||
WYE-354 is a potent, specific, and ATP-competitive inhibitor to mTOR with IC50 of 5 nM | ||||||
Mitotane | 53-19-0 | sc-205754 sc-205754A | 100 mg 1 g | $72.00 $166.00 | 1 | |
Mitotane is an adrenal cytotoxic agent | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $87.00 $147.00 | 5 | |
Letrozole is a CYP19 (aromatase) inhibitor | ||||||
Magnolol | 528-43-8 | sc-204797 sc-204797A | 5 mg 25 mg | $43.00 $189.00 | 1 | |
Magnolol is an inhibitor of NO and TNF-α production | ||||||
MT-21 | 186379-49-7 | sc-221959 sc-221959A | 10 mg 50 mg | $245.00 $872.00 | ||
MT-21 is a cell-permeable apoptosis inducing agent that causes release of cytochrome c | ||||||
Nedaplatin | 95734-82-0 | sc-202238 sc-202238A | 10 mg 25 mg | $117.00 $348.00 | ||
Nedaplatin is a platinum complex that has potent antineoplatic activity | ||||||